BernardRavinaMD
Psychiatry • Rochester, NYVice President of Clinical Development at Voyager Therapeutics
Are you Dr. Ravina?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 52 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
601 Elmwood Ave
Box 278984
Rochester, NY 14642Phone+1 585-275-8503Fax+1 585-276-2249
Summary
- Dr. Bernard Ravina, MD is a psychiatrist in Rochester, New York. He is currently licensed to practice medicine in New York and Massachusetts.
Education & Training
University of Pennsylvania Health SystemResidency, Neurology, 1996 - 1999
UPMC Medical EducationInternship, Internal Medicine, 1995 - 1996
Johns Hopkins University School of MedicineClass of 1995
Certifications & Licensure
MA State Medical License 2013 - 2018
NY State Medical License Active through 2013
Clinical Trials
- NINDS Parkinson's Disease Neuroprotection Trial of CoQ10 and GPI 1485 Start of enrollment: 2004 Jan 01
- Diagnostic and Prognostic Biomarkers in Parkinson Disease Start of enrollment: 2007 Aug 01
- Spectroscopy in Parkinson Disease Start of enrollment: 2009 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- 985 citationsThe Parkinson Progression Marker Initiative (PPMI)Kenneth Marek, Danna Jennings, Shirley Lasch, Andrew Siderowf, Caroline M. Tanner
Progress in Neurobiology. 2011-12-01 - 19 citationsImproved stratification of ALS clinical trials using predicted survival.James D. Berry, Albert A. Taylor, Danielle Beaulieu, Lisa Meng, Amy Bian
Annals of Clinical and Translational Neurology. 2018-03-09 - 15 citationsPharmacokinetics and pharmacodynamics of multiple doses of BG00010, a neurotrophic factor with anti‐hyperalgesic effects, in patients with sciaticaPieter Okkerse, Justin L. Hay, Eve Versage, Yongqiang Tang, Gerald R. Galluppi
British Journal of Clinical Pharmacology. 2016-05-13
Press Mentions
Praxis Precision Medicines to Present Data from PRAX-944 for Essential Tremor at 2022 American Academy of Neurology Annual MeetingApril 1st, 2022
Praxis Precision Medicines Launches with over $100 Million to Advance Pipeline of High Impact Therapies for Brain DisordersMay 4th, 2020- Differences in the Presentation and Progression of Parkinson's Disease by SexApril 8th, 2020
- Join now to see all
Professional Memberships
- Member
